Bioscience is a fundamentally important sector for the UK’s health and wealth. Last year we published our report Celebrating UK bioscience: unravelling the stories behind UK bioscience success, which details just some examples of UK bioscience success. 

Today we take a look at Humira, the world’s top-selling medicine that helps almost half a million people across the world to live with a range of debilitating and often painful conditions, including rheumatoid arthritis and Crohn’s disease. Humira was the first ever “fully human monoclonal antibody” treatment and it was conceived at the heart of UK bioscience.

RA infographic

Download the series of infographics here

Keep an eye out for the next phase of our Celebrate project, launching at this year’s UK Bioscience Forum on 20 October…